Last updated 13 days ago

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

80 patients around the world
Available in Spain, United States, Brazil
Hoffmann-La Roche
1Research sites
80Patients around the world
This study is for people with
Idiopathic Nephrotic Syndrome
Requirements for the patient
To 25 Years
All Gender
Medical requirements
Sites
Fundação Faculdade Regional de Medicina de São José do Rio Preto
Recruiting
Av. Brg. Faria Lima, 5544 Sao Jose do Rio Preto - Estado de São Paulo 15090-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy